Secondary Peritonitis

Antifungal Therapy

Empiric antifungal therapy is generally NOT indicated for GI perforation unless patient has one of the following risk factors:

  •  Esophageal perforation,

  •  Immunosuppression

  •  Prolonged antacid therapy

  • Prolonged antibiotic therapy

  •  Prolonged hospitalization

  •  Persistent GI leak

Initial Empiric Therapy

*Clinically stable patients without prior long-term azole therapy.